Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/21/2000 | US6040437 A polypeptide having the ability to bind a tyrosine phosphatase which contains a noncatalytic domain; inducing polymerization of actin monomers in eukaryotic cells; antagonists, agonists |
03/21/2000 | US6040436 A cdna; diangosis and therapy of central nervous system disorders, antiischemic agents, therapy for lambert-eaton syndrome |
03/21/2000 | US6040435 Antimicrobial cationic peptides |
03/21/2000 | US6040431 Single chain analogs of the TGF-β superfamily (morphons) |
03/21/2000 | US6040430 Nucleic acid encoding site specific recombinase and nuclear receptor fusion protein |
03/21/2000 | US6040429 Congenital heart disease proteins and products related thereto |
03/21/2000 | US6040428 Porcine E-selectin |
03/21/2000 | US6040427 A recombinant dna molecule comprising of a modified b-oligomer dimer encoding a protein that is reactive with antibodies against the wild type gene but is defective in pertussis toxin target cell receptor binding; therapy |
03/21/2000 | US6040426 Human Th2 specific protein |
03/21/2000 | US6040425 Myc homology region II--associated protein |
03/21/2000 | US6040424 Protein and gene for antioxidant response |
03/21/2000 | US6040423 Solid phase synthesis using one-piece support to synthesize a plurality of different peptides by spotting n-protected amino acid solution in discrete zones, coupling c-terminal to support, then coupling additional amino acids |
03/21/2000 | US6040421 Escherichia coli O157:H7 epithelial adhesion and vaccine |
03/21/2000 | US6040293 A microbial polypeptides with antimicrobial activity; fungicides, viricides, bactericides |
03/21/2000 | US6040291 Antimicrobial peptide |
03/21/2000 | US6040290 Antitumor agents for inhibiting the growth of adenocarcinoma cells |
03/21/2000 | US6040193 Combinatorial strategies for polymer synthesis |
03/21/2000 | US6040175 AMPA-binding human GluR2 receptors |
03/21/2000 | US6040174 Defective adenoviruses and corresponding complementation lines |
03/21/2000 | US6040173 Nucleic acid encoding a novel mammalian protein associated with uncontrolled cell division |
03/21/2000 | US6040170 Human cytomegalovirus DNA sequences |
03/21/2000 | US6040168 Dna and amino acid sequence of protein involved in neurotransmission and neurodevelopment; for diagnosis and treatment of schizophrenia and other nervous system disorders; screening drugs |
03/21/2000 | US6040166 Kits for amplifying and detecting nucleic acid sequences, including a probe |
03/21/2000 | US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides |
03/21/2000 | US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides |
03/21/2000 | US6040157 Amino acid sequence; for angiogenesis inhibitors, antitumor agents, antiinflammatory agents, antiarthritic agents for rheumatoid arthritis, wound healing agents; treatment of diabetic retinopathy and psoriasis |
03/21/2000 | US6040148 Heat shock protein/antigen having molecular weight of about 86 kilodaltons which induces an antibody to a breakdown product in recovering patients; for immunoassay diagnosis, immunogens and bactericides with reduced side effects |
03/21/2000 | US6040146 Detection of mammary tumor virus-like sequences in human breast cancer |
03/21/2000 | US6040145 Potentiation of the immune response |
03/21/2000 | US6040143 Canine nucleotide sequence; for hybridization assays to detect carriers of genetic defect which is single-base deletion in exon 4 |
03/21/2000 | US6040142 Method and probes for detecting markers linked to the infantile spinal muscular atrophy locus |
03/21/2000 | US6040140 Probes for use in diagnosis of acute lymphoblastic or nonlymphoblastic leukemia |
03/21/2000 | US6040137 Amino acid sequence of antibody which specifically binds a certain antigen linked to amino acid sequence to which a certain antibody binds; immunoassay diagnostic reagents; therapy by redirecting specificity of patient's antibodies |
03/21/2000 | US6040136 Phagemid expression vector having a transcription regulatory sequence linked to gene encoding a fusion protein of a polypeptide and a bacteriophage coat protein; for library of proteins expressed in low quantity on particle surface |
03/21/2000 | US6040134 Contacting fetal antigen 1 with t cells of subject and detecting response as indication of insulin-dependent diabetes mellitus |
03/21/2000 | US6040133 D-enzyme compositions and methods of their use |
03/21/2000 | US6039957 Oligomeric HIV-1 envelope glycoproteins |
03/21/2000 | US6039956 Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder |
03/21/2000 | US6039948 Amino acid sequences with beta subunit of chorionic gonadotropin endogenous to mammals |
03/21/2000 | US6039947 Peptides and amino acid sequences for stimulating for treatment of multiple sclerosis |
03/21/2000 | US6039945 Administering purified prothrombinase factor to humans |
03/21/2000 | US6039941 Live vaccine for the treatment of tumor diseases |
03/21/2000 | CA2048655C Discrimination between antibodies against htlv-1, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits |
03/21/2000 | CA2030518C Osteoinductive compositions |
03/21/2000 | CA2003361C Human vascular permeability factor |
03/21/2000 | CA1340931C Infectious bural disease virus |
03/16/2000 | WO2000014271A1 METHOD FOR STUDYING PROTEIN INTERACTIONS $i(IN VIVO) |
03/16/2000 | WO2000014266A1 Recombinant human sm-11044-binding receptor protein having activity of binding to ligand and utilization thereof |
03/16/2000 | WO2000014265A1 Enzymatic oxidative deamination process |
03/16/2000 | WO2000014263A2 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them |
03/16/2000 | WO2000014261A1 Production of human erythropoietin |
03/16/2000 | WO2000014259A1 Candida boidinii strains having lowered protease activity and utilization thereof as host for producing foreign protein |
03/16/2000 | WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
03/16/2000 | WO2000014255A1 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES |
03/16/2000 | WO2000014253A1 Nucleic acids and proteins from pineapple stem |
03/16/2000 | WO2000014250A1 Tyrosylprotein sulfotransferase polypeptides and polynucleotides |
03/16/2000 | WO2000014245A1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
03/16/2000 | WO2000014244A2 Treatment of cervical cancer |
03/16/2000 | WO2000014242A1 Novel protein, gene encoding the same and utilization thereof |
03/16/2000 | WO2000014241A1 Novel gene |
03/16/2000 | WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers |
03/16/2000 | WO2000014239A2 Thioredoxin h homologs |
03/16/2000 | WO2000014238A1 Maize repair protein orthologue-1 and uses thereof |
03/16/2000 | WO2000014237A2 17 kDa FOAM PROTEIN |
03/16/2000 | WO2000014236A2 Grf analogs with increased biological potency |
03/16/2000 | WO2000014235A1 Kunitz domain polypeptide zkun6 |
03/16/2000 | WO2000014233A1 14275 receptor, a novel g-protein coupled receptor related to the edg receptor family |
03/16/2000 | WO2000014232A1 Hypertension associated transcription factor-1 (hatf-1) and hatf related protein 1 (hrp-1) |
03/16/2000 | WO2000014231A1 Lim domain protein homolog |
03/16/2000 | WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
03/16/2000 | WO2000014229A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
03/16/2000 | WO2000014228A1 Neutral amino acid transporter and gene thereof |
03/16/2000 | WO2000014226A1 Novel protein and process for producing the same |
03/16/2000 | WO2000014225A1 Putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits, cacnglike2 (calcium channel gamma like 2) |
03/16/2000 | WO2000014224A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits |
03/16/2000 | WO2000014223A1 Voltage-gated calcium channel |
03/16/2000 | WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF |
03/16/2000 | WO2000014221A1 Glycine transporter |
03/16/2000 | WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
03/16/2000 | WO2000014215A1 Method for selecting peptides for the targeted transport of drugs and markers, and peptides discovered using said method |
03/16/2000 | WO2000014211A1 ADENOVIRUS EXPRESSION VECTOR ENCODING THE TUMOR SUPPRESSOR GENE p16 AND A METHOD OF USING |
03/16/2000 | WO2000014210A1 Systemic carnitine deficiency gene and utilization thereof |
03/16/2000 | WO2000014209A1 Endothelial cell proliferation inhibitors derived from human prothrombin |
03/16/2000 | WO2000014205A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
03/16/2000 | WO2000014204A1 Nerve cell death receptor |
03/16/2000 | WO2000014201A1 Polypeptides containing modified, non-natural amino acids and methods of production |
03/16/2000 | WO2000014200A2 Essential bacterial genes and their use |
03/16/2000 | WO2000014117A1 Peptide ligands for affinity purification of human factor viii |
03/16/2000 | WO2000014116A1 T cell peptides as therapeutics for immune-related disease |
03/16/2000 | WO2000014115A1 Mc4-r as target for the identification of compounds used to treat drug addiction |
03/16/2000 | WO2000014114A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants |
03/16/2000 | WO2000014112A2 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby |
03/16/2000 | WO2000014110A1 CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
03/16/2000 | WO2000014108A1 Monitor protein for measuring phosphorylation of protein |
03/16/2000 | WO2000014107A1 Temperature dependent protein purification |
03/16/2000 | WO2000014106A1 Novel bag proteins and nucleic acid molecules encoding them |
03/16/2000 | WO2000014105A1 Modifications of the vegf receptor-2 protein and methods of use |
03/16/2000 | WO2000014103A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins |
03/16/2000 | WO2000013700A1 Method of using fetuin to induce apoptosis in cancer cells |
03/16/2000 | WO2000013699A1 An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor |